Therefore, cutaneous IgE-mediated LPRs have been used as a screening atopic dermatitis model for studying the anti-inflammatory effect of anti-allergic drugs before entering clinical trials [6,7,8,9]. The gene discussed is IGHE; the disease is atopic eczema.